Maziar Assadi Gehr

Maziar Assadi Gehr, MD, is a Senior Medical Director at Ironwood Pharmaceuticals since August 2024, with prior experience as a consultant in the pharmaceutical industry and as a Medical Director at Basilea Pharmaceutica, where medical leadership was provided for adult and pediatric programs related to Staphylococcus aureus bacteremia and late-onset sepsis, involving interactions with regulatory authorities such as the FDA and EMA. Previous roles include Global Medical Affairs Physician at Actelion, overseeing phase IIIb/IV clinical studies in pulmonary arterial hypertension, and Medical Manager at Roche, managing research budgets for approved medicines in osteoporosis and rheumatoid arthritis. Maziar Assadi Gehr began medical training at the University Hospital of Bern, followed by the University Hospital of Zurich, and completed postgraduate training in Experimental Medicine at the University of Zurich. Educational credentials include an MD from the University of Basel and advanced training in medical genomics at the University of Zurich.